BENMELSTOBART

Clinical trials for BENMELSTOBART explained in plain language.

Never miss a new study

Get alerted when new BENMELSTOBART trials appear

Sign up with your email to follow new studies for BENMELSTOBART, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New triple combo aims to tackle Hard-to-Treat liver cancer

Disease control Not yet recruiting

This phase 2 trial tests a combination of two drugs (Benmelstobart and Anlotinib) plus targeted radiation (SBRT) in 29 adults with liver cancer that has spread to a few other spots and no longer responds to first-line treatment. The goal is to see if this triple therapy can slow …

Matched conditions: BENMELSTOBART

Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated Jun 27, 2026 12:08 UTC

BENMELSTOBART

Get alerted when new BENMELSTOBART trials appear

New triple combo aims to tackle Hard-to-Treat liver cancer